Related Experiment Video
Updated: May 7, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
How I treat severe combined immunodeficiency
H Bobby Gaspar1, Waseem Qasim, E Graham Davies
1Centre for Immunodeficiency, Molecular Immunology Unit, University College London Institute of Child Health, London, United Kingdom; and.
Severe combined immunodeficiency (SCID) is a group of genetic disorders affecting lymphocyte development. Advances in hematopoietic stem cell transplantation and gene therapy offer improved survival and tailored treatments for SCID patients.
Area of Science:
- Immunology
- Genetics
- Pediatrics
Background:
- Severe combined immunodeficiency (SCID) comprises genetic defects impairing lymphocyte development and function, leading to severe infections.
- Allogeneic hematopoietic stem cell transplantation (HSCT) is a primary treatment for restoring immunity in SCID patients.
Observation:
- Multicenter studies have identified key factors for successful HSCT outcomes, significantly improving SCID survival rates.
- Understanding the genetic basis of SCID allows for tailored transplant protocols, including reduced-intensity conditioning where feasible.
Findings:
- While HSCT survival is high, specific SCID forms may still present with residual humoral defects.
- Autologous hematopoietic stem cell gene therapy is a viable treatment for X-linked SCID and adenosine deaminase-deficient SCID.
- The use of matched related/unrelated donors and cord blood is prioritized over mismatched haploidentical donors.
Implications:
- Integrating gene therapy into treatment strategies enhances therapeutic options for specific SCID subtypes.
- Universal newborn screening for SCID, coupled with advanced treatments, promises highly favorable outcomes for this previously lethal condition.
More Related Videos
14:14Simultaneous Quantification of T-Cell Receptor Excision Circles TRECs and K-Deleting Recombination Excision Circles KRECs by Real-time PCR
Published on: December 6, 2014
10:24Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Cystic Fibrosis: Management
Sinus disease and chronic...
Cytomegalovirus Disease